Endobronchial ultrasound has been one of the success stories of the last decade, and the utility of the procedure continues to expand. Originally, it was developed for the staging and diagnosis of lung cancer, but its use rapidly expanded to other malignancies and even benign disease. We present the case of a patient originally referred with suspected endocarditis who was found to have a mass involving the right ventricle and the pulmonary outflow tract. Endobronchial ultrasound-guided biopsy was used to obtain a tissue diagnosis from the cardiac mass.

Keywords:
Endobronchial ultrasound, Bronchoscopy, Convex probe endobronchial ultrasound, Angiosarcoma, Transbronchial needle aspiration
1.
De Leyn P, Dooms C, Kuzdzal J, et al: Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 2014;45:787-798.
2.
Annema JT, van Meerbeeck JP, Rintoul RC, Dooms C, Deschepper E, Dekkers OM, De Leyn P, Braun J, Carroll NR, Praet M, de Ryck F, Vansteenkiste J, Vermassen F, Versteegh MI, Veseliç M, Nicholson AG, Rabe KF, Tournoy KG: Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA 2010;304:2245-2252.
3.
Von Bartheld MB, Dekkers OM, Szlubowski A, et al: Endosonography versus conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA 2013;309:2457-2464.
4.
Adams K, Shah PL, Edmonds L, Lim E: Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax 2009;64:757-762.
5.
Nicholson AG, Gonzales D, Shah P, et al: Refining the diagnosis and EGFR status of non-small cell carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6 and P63, and mutation analysis. J Thorac Oncol 2010;5:436-441.
6.
Mayer F, Aebert H, Rudert M, et al: Primary malignant sarcomas of the heart and great vessels in adult patients - a single centre experience. Oncologist 2007;12:1134-1142.
7.
Burke AP, Virmani R: Sarcomas of the great vessels. A clinicopathologic study. Cancer 1993;71:1761-1773.
8.
Crymes TP, Fish RG, Smith DE: Complications of transbronchial left atrial puncture. Am Heart J 1959;58:46-52.
9.
Horowitz JC, Kleaveland K, Arenberg D: Endobronchial biopsy of an intrapulmonary arterial mass. J Bronchology Interv Pulmonol 2013;20:93-95.
10.
Dusemund F, Schneider T, Zeisel C, Rothermundt C, Kluckert T, Schmid S, Brutsche MH: Endobronchial ultrasound-guided transbronchial needle aspiration of an intravascular sarcoma metastasis. Respiration 2013;86:430-432.
11.
Wang KP, Terry PB: Transbronchial needle aspiration in the diagnosis and staging of bronchogenic carcinoma. Am Rev Respir Dis 1983;127:344-347.
12.
Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A: Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006;61:795-798.
13.
Talbot SM, Taub RN, Keohan ML, Edwards N, Galantowicz ME, Schulman LL: Combined heart and lung transplantation for unresectable primary cardiac sarcoma. J Thorac Cardiovasc Surg 2002;124:1145-1148.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.